On the morning of October 1st, the celebration of Lean Digital Twin Intelligent Factory of Borosilicate Medicinal Glass in Linotebo (Stock Code: 301188.SZ) was held ceremoniously. This is another important achievement of the third phase of the high-end pharmaceutical packaging intelligent manufacturing project in Linuotebo, following the third-level certification of national intelligent manufacturing capability maturity in August and being rated as 2024 provincial intelligent factory by Shandong Provincial Department of Industry and Information Technology.
Sun Pengfei, president of Linotebo, presided over the meeting to welcome all the distinguished guests and gave a brief introduction to Linotebo: as the first listed company of Linuo Group, Linotebo began in 1995, is a new glass material high-tech enterprise, listed on the gem of Shenzhen Stock Exchange on November 11, 2021, stock code 301188.SZ, now has three series of products of pharmaceutical packaging, heat-resistant glass and optical glass. With the whole industry chain, leading technology, diversified products, excellent quality and first-class service, it has won the recognition of global customers, and the products sell well in many countries in the world.
Chairman Yang Zhongchen expressed his heartfelt thanks to all levels of government, industry associations, partners and customers who have supported and helped Linotebo for a long time. He said that the launch of the Lean Digital Twin Intelligent Factory of Borosilicate Medicinal Glass in Linotebo will use advanced technology to realize accurate control, intelligent scheduling and efficient coordination in the production process of medicinal glass packaging materials. This is Linotebo's solid step towards higher quality, higher efficiency and more intelligent production.
Cui Chengzhong, general manager of Linuote Glass Molding bottle Division, detailed the general situation of China Borosilicate Medicinal Glass Lean Digital Twin Intelligent Factory. The Lean Digital Twin Factory of Borosilicate Medicinal Glass in Linuotebo mainly produces molded bottles of Borosilicate Medicinal Glass. Automation, information and intelligent technologies are introduced into the Lean Digital Twin Intelligent Factory. These technologies are deeply integrated with the concept of lean production and the principle of green and low carbon, thus achieving a significant improvement in production efficiency and product quality. It marks a great leap forward for the enterprise to the production mode of high efficiency, high quality and low cost. This transformation not only optimizes the allocation of resources, but also enhances Linotebo's rapid response to the market, provides a strong driving force for Linotebo's continuous innovation and green development, and further leads the overall upgrading of the industry.
Chen Xiaodong, chairman of the standing Committee of Shanghe County people's Congress, said in his speech that the launch of the Lean Digital Twin Intelligent Factory of Borosilicate Medicinal Glass in Linuotebo has injected a strong driving force into the regional economic growth, and the local area will fully support the development of enterprises in the area. To make greater contributions to the realization of high-quality development and green sustainable goals.
Cui Yaqing, executive deputy secretary-general of Shandong Pharmaceutical Industry Association, said that the Lean Digital Twin Intelligent Factory of Borosilicate Medicinal Glass in Linuotebo is a model of the industry, which will effectively promote the whole industry to a higher level of development. the association will continue to support the development of Lenotebo and other representative enterprises, and jointly promote the prosperity and progress of the pharmaceutical industry.
Many industry associations and pharmaceutical companies expressed high concern and appreciation for this, and sent congratulatory letters one after another, expressing warm congratulations on Linotebo's breakthrough in the field of intelligent manufacturing. In the congratulatory letter of the industry association, it not only expresses the recognition of Lenoft's technological innovation, but also reveals its expectation and confidence in promoting the whole industry to a higher level of development in the future.
Customer representatives of pharmaceutical enterprises put forward that cooperation will be further strengthened, and hope to make use of Linotebo's advantages in intelligent manufacturing to jointly promote the digital transformation and intelligent upgrading of the pharmaceutical industry, and jointly explore more innovative technologies and solutions. enhance the overall competitiveness of the pharmaceutical industry and provide patients with more quality drugs and services.
As an intelligent manufacturing benchmark enterprise in Shandong Province, Linotebo (stock code: 301188.SZ) third phase of high-end pharmaceutical packaging intelligent manufacturing project with a total investment of 2 billion yuan, landed in Shanghe in 2022, is a major implementation project in Shandong Province in 2023 and a key green, low-carbon and high-quality development project in Shandong Province in 2024. The project is based on industrial positioning, focusing on the development of pharmaceutical packaging, focusing on medium borosilicate glass molded bottle production line, and building a high-end pharmaceutical packaging production base. The factory focuses on green, low carbon and sustainable development, introduces digital energy carbon management, relies on intelligent manufacturing to achieve low consumption and low emissions, builds a green, low carbon and circular intelligent manufacturing system, promotes carbon neutralization and ESG, creates transparent factories, green factories and lighthouse factories, promotes the company's green, healthy and sustainable development, and sets an example for the green development of the industry.
